Recalls
Searchable archive of product recalls from the FDA, USDA FSIS, CPSC, NHTSA, and EPA — translated into plain English, severity-scored from objective criteria, and always linked back to the original government notice.
Every recall on this list has been scored 1–5 against an objective rubric from the agency’s own classification, presence of reported injuries or deaths, distribution scope, and hazard type. The colored severity badge on each card is the score — 5 (Critical) means deaths or serious injuries are reported, 4 (Severe) means significant injury or hospitalization risk, and 3 (High) means a known hazard with no confirmed harm yet. Filter to 3+ (High and above) if you want to skip routine Class-III notices.
The agency chips above control which streams are visible. FDA spans food, drugs, and medical devices. USDA FSIS is meat, poultry, and processed egg products. CPSC is household consumer products. NHTSA is vehicles, tires, and child seats. Nationwide on a card means the recall affects every US state — most do — while a state list means distribution was limited.
Click any recall to see the full summary, affected lot codes and model numbers, the agency’s own classification, and a direct link back to the original government notice for verification.
Minimum severity
Infusion Options, Inc. is recalling Pembrolizumab 200 mg/100 mL IV products in New York due to a lack of assurance of sterility.
Infusion Options, Inc. is recalling SOLIRIS 1200 mg and 900 mg IV products in New York due to a lack of assurance of sterility.
Infusion Options, Inc. is recalling DARZALEX 1008 mg / 500 mL IV infusion bags in New York due to a lack of assurance of sterility.
Infusion Options, Inc. is recalling various Gemcitabine infusion bags in New York due to a lack of assurance of sterility.
Infusion Options, Inc. is recalling preservative-free 0.9% sodium chloride 5 mL syringes in New York due to a lack of assurance of sterility.
Infusion Options, Inc. is recalling various strengths of Carfilzomib infusions in New York due to a lack of assurance of sterility.
The FDA is recalling DARATUMUMAB infusion solutions because sterility cannot be assured, creating a potential infection risk.
Infusion Options, Inc. is recalling multiple Trastuzumab infusion bags in New York due to a lack of assurance of sterility.
Infusion Options, Inc. is recalling Azacitidine syringes in New York due to a lack of assurance of sterility.
Infusion Options, Inc. is recalling various Cyclophosphamide infusion products in New York due to a lack of assurance of sterility.
Infusion Options, Inc. is recalling HERCEPTIN infusion bags in New York due to a lack of assurance of sterility.
Infusion Options, Inc. is recalling various Docetaxel infusion bags in New York due to a lack of assurance of sterility.
US Pharmaceuticals is recalling 246 cases of Cool Hot Ice Analgesic Gel because the purified water used in manufacturing failed quality tests for microbial count or organic carbon.
American Health Packaging is recalling Carbamazepine Extended-Release Tablets, 400 mg, because they failed to meet dissolution specifications.
Alvogen, Inc. is recalling 4,272 bottles of Macrobid (nitrofurantoin monohydrate/macrocrystalline) 100 mg tablets because they failed dissolution specifications.
US Pharmaceuticals is recalling specific lots of Maximum Strength Hydrocortisone Cream with Aloe because the purified water used in manufacturing failed quality tests.
US Pharmaceuticals is recalling CRYO-273 Cold Pain Relieving Gel because the purified water used in manufacturing failed quality tests for microbial count or organic carbon.
US Pharmaceuticals is recalling 651 cases of Maximum Strength Hydrocortisone Cream because the purified water used in manufacturing failed quality tests for microbial count or organic carbon.
US Pharmaceuticals is recalling Wonder Freeze Pain Relieving Gel because the purified water used in manufacturing failed quality tests for microbial count or organic carbon.
US Pharmaceuticals is recalling 830 tubes of Soothe&Cool Protect Moisture Guard Skin Protectant due to out-of-specification results for microbial count or organic carbon in purified water.
US Pharmaceuticals is recalling 196 cases of Adult Glycerin Suppositories because the purified water used in manufacturing failed quality tests for microbial count or organic carbon.
US Pharmaceuticals is recalling CVS Therapeutic Menthol Gel because the purified water used in manufacturing failed quality tests for microbial count or organic carbon.
US Pharmaceuticals is recalling CVS Health Glycerin Suppositories due to out-of-specification results for microbial count or organic carbon in the purified water used during manufacturing.
US Pharmaceuticals is recalling Kool Comfort Cooling Pain Relief because the purified water used in manufacturing failed quality tests for microbial count or organic carbon.
US Pharmaceuticals is recalling Intensive Healing Eczema Lotion due to out-of-specification results for microbial count or organic carbon in the purified water used during manufacturing.